Cargando…

Impact of Hyperglycemia and Diabetes Mellitus on Breakthrough Mucormycosis Outcomes in Patients with Hematologic Malignancies—Complex and Intriguing Associations

Mucormycosis (MCR) is frequently associated with diabetic ketoacidosis and hyperglycemia, as well as hematologic malignancies (HMs) and hematopoietic stem cell transplantation (HSCT). However, little is known about the effect of hyperglycemia on MCR outcomes in patients with HMs. We therefore conduc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Franklin, Alexander, Wurster, Sebastian, Axell-House, Dierdre B., Jiang, Ying, Kontoyiannis, Dimitrios P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860539/ https://www.ncbi.nlm.nih.gov/pubmed/36675866 http://dx.doi.org/10.3390/jof9010045

Ejemplares similares

848. Discordant Chest Radiography and Computed Tomography Findings in Patients with Hematologic Malignancy and Invasive Mucormycosis: What Are the Prognostic Implications?
por: Wurster, Sebastian, et al.
Publicado: (2023)

Breakthrough Mucormycosis Developing on Mucorales-Active Antifungals Portrays a Poor Prognosis in Patients with Hematologic Cancer
por: Axell-House, Dierdre B., et al.
Publicado: (2021)

710. Comparison of Initial CXR to CT in Patients (pts) with Hematologic Malignancy (HEM) and Documented Symptomatic Pulmonary Mucormycosis (PM)
por: Franklin, Alexander, et al.
Publicado: (2021)

2102. Common co-occurence in the respiratory tract of Mucorales with Gram-negative rods in patients with hematologic malignancy and sinopulmonary mucormycosis
por: Egge, Stephanie L, et al.
Publicado: (2022)

Taking a Closer Look: Clinical and Histopathological Characteristics of Culture-Positive versus Culture-Negative Pulmonary Mucormycosis
por: Spallone, Amy, et al.
Publicado: (2022)

255. Breakthrough Mucormycosis (BT-MCR) on Antifungals Having Mucorales Activity Portrays Worse Prognosis compared with BT-MCR on Mold-Active Antifungals with no Mucorales Activity
por: Axell-House, Dierdre B, et al.
Publicado: (2019)

828. Do lung co-infections influence outcome in patients with hematological malignancies and culture-documented invasive pulmonary aspergillosis?
por: Matsuo, Takahiro, et al.
Publicado: (2023)

Clinical Approach to Evaluation of Underlying Cardiac Device Infection in Patients Hospitalized with Bacteremia
por: Axell-House, Dierdre B., et al.
Publicado: (2023)

When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis
por: John, Teny M., et al.
Publicado: (2021)

Therapy of Mucormycosis
por: Sipsas, Nikolaos V., et al.
Publicado: (2018)

Mucormycosis of the Central Nervous System
por: Chikley, Amanda, et al.
Publicado: (2019)

Invasive Fungal Infections at Presentation of Untreated Hematologic Malignancies: Rare and Elusive
por: Spallone, Amy, et al.
Publicado: (2020)

Mucormycosis in 2023: an update on pathogenesis and management
por: Alqarihi, Abdullah, et al.
Publicado: (2023)

CAR T-Cell Therapy: On the Verge of Breakthrough in Many Hematologic Malignancies
por: Stadtmauer, Edward, et al.
Publicado: (2017)

Outcomes of Breakthrough COVID-19 Infections in Patients with Hematologic Malignancies
por: Chien, Kelly S., et al.
Publicado: (2022)

Outcomes of breakthrough COVID-19 infections in patients with hematologic malignancies
por: Chien, Kelly S., et al.
Publicado: (2023)

Blockade of the PD-1/PD-L1 Immune Checkpoint Pathway Improves Infection Outcomes and Enhances Fungicidal Host Defense in a Murine Model of Invasive Pulmonary Mucormycosis
por: Wurster, Sebastian, et al.
Publicado: (2022)

A Potential Explanation of a Positive Serum β-Glucan Assay in Mucormycosis
por: Kontoyiannis, Dimitrios P.
Publicado: (2016)

1521. Non-faecium Non-faecalis enterococcal bloodstream infections in patients with cancer
por: Axell-House, Dierdre B, et al.
Publicado: (2022)

2693. Epidemiology of Infections with Multidrug-Resistant Organisms in Patients with Left Ventricular Assist Devices (LVADs)
por: Axell-House, Dierdre B, et al.
Publicado: (2023)

Epidemiology and clinical manifestation of fungal infection related to Mucormycosis in hematologic malignancies
por: Noorifard, M, et al.
Publicado: (2015)

Clinical Features and Treatment Progress of Invasive Mucormycosis in Patients with Hematological Malignancies
por: Yang, Nuobing, et al.
Publicado: (2023)

The estimation of diagnostic accuracy of tests for COVID-19: A scoping review
por: Axell-House, Dierdre B., et al.
Publicado: (2020)

664. LiaX as a Surrogate Marker of Daptomycin Susceptibility in Multidrug-Resistant Enterococcus faecium Recovered from Cancer Patients
por: Axell-House, Dierdre B, et al.
Publicado: (2020)

Checkpoint inhibitors as immunotherapy for fungal infections: Promises, challenges, and unanswered questions
por: Wurster, Sebastian, et al.
Publicado: (2022)

355. Invasive Pulmonary Aspergillosis (IPA) Complicating Respiratory Viral Infections in Patients With Hematological Malignancies
por: Magira, Eleni, et al.
Publicado: (2018)

Metagenomic Next-Generation Sequencing for Diagnostically Challenging Mucormycosis in Patients with Hematological Malignancies
por: Zhang, Meng, et al.
Publicado: (2022)

Candida auris Bloodstream Infection Induces Upregulation of the PD-1/PD-L1 Immune Checkpoint Pathway in an Immunocompetent Mouse Model
por: Wurster, Sebastian, et al.
Publicado: (2022)

Growth hormone and gastrointestinal malignancy: An intriguing link
por: Palui, Rajan, et al.
Publicado: (2023)

Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey
por: Pagano, Livio, et al.
Publicado: (2022)

Therapeutic Challenges of Hepatic Mucormycosis in Hematologic Malignancy: A Case Report and Review of the Literature
por: Bernardo, Raffaele M., et al.
Publicado: (2016)

465. A Multifaceted and Multi-Institutional Analysis of the COVID19-Associated Mucormycosis Outbreak in the Delhi Area Indicates the Simultaneous Convergence of Multiple Risk Factors
por: Chowdhary, Anuradha, et al.
Publicado: (2022)

Sirolimus suppresses circulating fibrocytes in idiopathic pulmonary fibrosis in a randomized controlled crossover trial
por: Gomez-Manjarres, Diana C., et al.
Publicado: (2023)

Breakthrough Bacteremia with Meropenem-resistant Pseudomonas aeruginosa in Hematologic Malignancy Patients Receiving Levofloxacin Prophylaxis
por: Hakki, Morgan, et al.
Publicado: (2017)

415. Breakthrough Invasive Fungal Infections in Adult Hematologic Malignancy Patients Receiving Isavuconazole Prophylaxis
por: DeVoe, Catherine, et al.
Publicado: (2018)

Are Unique Regional Factors the Missing Link in India’s COVID-19-Associated Mucormycosis Crisis?
por: Skaria, Jessy, et al.
Publicado: (2022)

Seasonal clustering of sinopulmonary mucormycosis in patients with hematologic malignancies at a large comprehensive cancer center
por: Sivagnanam, Shobini, et al.
Publicado: (2017)

Mucormycosis in intensive care unit: surgery is a major prognostic factor in patients with hematological malignancy
por: Claustre, Johanna, et al.
Publicado: (2020)

Mucormycosis in Hematopoietic Cell Transplant Recipients and in Patients With Hematological Malignancies in the Era of New Antifungal Agents
por: Miller, Matthew A, et al.
Publicado: (2020)

359. Baseline Serum Aspergillus Galactomannan Index Among Aspergillus Species in Hematologic Malignancies Patients With Invasive Pulmonary Aspergillosis
por: Magira, Eleni, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rafodqrju673q9oanf1ihcc7m1